Terms: = Thyroid cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
14 results:
1. Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs.
Hong H; Chen H; Zhao J; Qin L; Li H; Huo H; Shi S
Mutat Res; 2023; 827():111830. PubMed ID: 37437506
[TBL] [Abstract] [Full Text] [Related]
2. Clinical model of pulmonary metastasis in patients with osteosarcoma: A new multiple machine learning-based risk prediction.
Su Z; Huang F; Yin C; Yu Y; Yu C
J Orthop Surg (Hong Kong); 2023; 31(2):10225536231177102. PubMed ID: 37288764
[TBL] [Abstract] [Full Text] [Related]
3. [Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy].
Ye T; Lai S; Cao B; Xu B; Wang R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):370-374. PubMed ID: 37138400
[No Abstract] [Full Text] [Related]
4. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast cancer.
Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
[TBL] [Abstract] [Full Text] [Related]
5. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
[TBL] [Abstract] [Full Text] [Related]
6. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies.
Dawwas GK; Hennessy S; Brensinger CM; Deo R; Bilker WB; Soprano SE; Dhopeshwarkar N; Flory JH; Bloomgarden ZT; Aquilante CL; Kimmel SE; Leonard CE
Clin Pharmacol Ther; 2022 Jan; 111(1):227-242. PubMed ID: 34331322
[TBL] [Abstract] [Full Text] [Related]
7. Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
Nishihara E; Ito Y; Kudo T; Ito M; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2021 Jun; 68(6):649-654. PubMed ID: 33551434
[TBL] [Abstract] [Full Text] [Related]
8. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.
Liu H; Yang D; Chen X; Sun Z; Zou Y; Chen C; Sun S
Cancer Med; 2021 Feb; 10(3):1043-1056. PubMed ID: 33381923
[TBL] [Abstract] [Full Text] [Related]
9. Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
Schlumberger M; Elisei R; Müller S; Schöffski P; Brose M; Shah M; Licitra L; Krajewska J; Kreissl MC; Niederle B; Cohen EEW; Wirth L; Ali H; Clary DO; Yaron Y; Mangeshkar M; Ball D; Nelkin B; Sherman S
Ann Oncol; 2017 Nov; 28(11):2813-2819. PubMed ID: 29045520
[TBL] [Abstract] [Full Text] [Related]
10. Tiotropium plus formoterol versus tiotropium alone for stable moderate-to-severe chronic obstructive pulmonary disease: A meta-analysis.
Zou Y; Xiao J; Lu XX; Xia ZA; Xie B; Li J; Chen Q
Clin Respir J; 2018 Jan; 12(1):269-278. PubMed ID: 27402142
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and safety of selumetinib compared with current therapies for advanced cancer: a meta-analysis.
Shen CT; Qiu ZL; Luo QY
Asian Pac J Cancer Prev; 2014; 15(5):2369-74. PubMed ID: 24716986
[TBL] [Abstract] [Full Text] [Related]
12. Syndrome of inappropriate antidiuretic hormone secretion induced by a single dose of oral cyclophosphamide.
Gilbar PJ; Richmond J; Wood J; Sullivan A
Ann Pharmacother; 2012 Sep; 46(9):e23. PubMed ID: 22911342
[TBL] [Abstract] [Full Text] [Related]
13. CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.
Strock CJ; Park JI; Rosen M; Dionne C; Ruggeri B; Jones-Bolin S; Denmeade SR; Ball DW; Nelkin BD
Cancer Res; 2003 Sep; 63(17):5559-63. PubMed ID: 14500395
[TBL] [Abstract] [Full Text] [Related]
14. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and bubr1.
Ouyang B; Knauf JA; Ain K; Nacev B; Fagin JA
Clin Endocrinol (Oxf); 2002 Mar; 56(3):341-50. PubMed ID: 11940046
[TBL] [Abstract] [Full Text] [Related]